Wayne, PA, United States of America

Simon John Hatch

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Pure Tech Lyt 100, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon John Hatch. Retrieved from https://idiyas.com/inventor/simon-john-hatch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Simon John Hatch: Inventor in Pulmonary Fibrosis Treatment

Introduction

Simon John Hatch is an inventor based in Wayne, Pennsylvania. His patent work concerns a potential treatment approach for idiopathic pulmonary fibrosis (IPF), a progressive lung disease.

Latest Patents

Hatch is associated with one patent, 1 patent: “Methods of Treating Idiopathic Pulmonary Fibrosis with Deupirfenidone.” The disclosed method involves administering deuterium-enriched pirfenidone, known as LYT-100, at a total daily dose of about 1,650 to 2,500 milligrams to a subject in need of treatment.

Career Highlights

Hatch is associated with PureTech Lyt 100, Inc. His patent work focuses on the use of deupirfenidone in treating IPF.

Collaborations

Hatch’s listed coworkers include Liza C. Micioni and David Andrew Golod.

Conclusion

Simon John Hatch’s patent activity centers on a proposed deupirfenidone treatment method for idiopathic pulmonary fibrosis, reflecting research into potential therapeutic approaches for the disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…